Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jul 28, 2014; 20(28): 9564-9569
Published online Jul 28, 2014. doi: 10.3748/wjg.v20.i28.9564
Published online Jul 28, 2014. doi: 10.3748/wjg.v20.i28.9564
Table 2 Association between hepatoma-derived growth factor expression and the clinicopathological characteristics of gallbladder cancer n (%)
| Parameter | Category | Cases (n) | HDGF | ||
| Positive cases | χ2 | P value | |||
| Age | < 60 | 9 | 8 (88.9) | 0.227 | 0.634 |
| ≥ 60 | 31 | 23 (74.2) | |||
| Sex | Male | 11 | 7 (63.6) | 0.755 | 0.385 |
| Female | 29 | 24 (82.8) | |||
| Histopathological subtypes | High | 8 | 3 (37.5) | 8.027 | 0.018 |
| Middle | 14 | 12 (85.7) | |||
| Low | 18 | 16 (88.9) | |||
| TNM stage | 0-I | 5 | 1 (20.0) | 7.349 | 0.007 |
| II-IV | 35 | 30 (85.7) | |||
| Lymph node metastasis | Negative | 19 | 14 (73.7) | 0.029 | 0.865 |
| Positive | 21 | 17 (83.0) | |||
| Perineural invasion | Absent | 12 | 5 (41.7) | 9.858 | 0.002 |
| Present | 28 | 26 (92.9) | |||
| Gallbladder stones | Negative | 17 | 14 (82.4) | 0.152 | 0.697 |
| Positive | 23 | 17 (77.3) | |||
- Citation: Tao F, Ye MF, Sun AJ, Lv JQ, Xu GG, Jing YM, Wang W. Prognostic significance of nuclear hepatoma-derived growth factor expression in gallbladder cancer. World J Gastroenterol 2014; 20(28): 9564-9569
- URL: https://www.wjgnet.com/1007-9327/full/v20/i28/9564.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i28.9564